GlassScriptPhysician profile
Eric A Lisznyai
NPI 1831764240
$1,693.30
in general payments reported to CMS, 2019-2025
9 companies · $426 in 2025
The $426 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $693 · 2024: $575 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,468 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.37 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $381.31 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| My01 INC. | $347.88 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Bolton Medical INC | $168.56 | 2025 | Thoraflex Hybrid |
| Medtronic, INC. | $149.98 | 2024 | Signia |
| Acera Surgical, INC. | $144.77 | 2024 | Restrata Wound Matrix |
| Teleflex LLC | $117.82 | 2025 | Quikclot |
| W. L. Gore & Associates, INC. | $87.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $70.78 | 2025 | N/A, Enseal, Harmonic |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lisznyai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.